Savaş et al. 2020 demonstrated the importance of oxidative stress and inflammation in MetS by investigating the roles of macrophage apoptosis inhibitor (AIM) and monocyte chemotactic protein-1 (MCP-1). Here, CCL2 is linked to metabolic syndrome.